• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Elimination of alkyl phosphates by means of haemoperfusion: experimental results and findings from human casuistics (author's transl)].

作者信息

Okonek S, Albert F W

出版信息

Anaesthesist. 1976 Dec;25(12):572-8.

PMID:1008248
Abstract

We examined the possibility that haemoperfusion with coated activated charcoal might be used in the therapy of alkyl phosphate intoxications. The criterion used was the effect of haemoperfusion on the elimination of alkyl phosphates from the blood. Clearance values for haemoperfusion of nitrostigmine, demeton-S-methyl sulfoxide and dimethoate were determined in vitro. Very good clearance values were ascertained at a blood flow rate of 100ml/min (mitrostigmine 59.20ml/min, demeton-S-methyl sulfoxide 83.70 ml/min, dimethoate 87.84 ml/min). Measurements of the nitrostigmine clearance as a function of various nitrostigmine concentrations in plasma showed that haemoperfusion is effective over a concentration range covering two powers of ten. A 7-h haemoperfusion with coated activated charcoal was performed on a suicide patient with severe nitrostigmine intoxication (Folidol-öl). Clearance values were obtained which were to be expected on the basis of the in vitro investigations. The nitrostigmine concentrations in the extracorporeal blood plasma fell as a result of haemoperfusion to a mid-value of 55 per cent of the initial level. In the patient the level of nitrostigmine in the blood rose showing that there had been a redistribution of nitrostigmine from the tissue or a subsequent absorption from the gastrointestinal tract into the vessels. The results support the use of haemoperfusion with coated activated charcoal in very severe cases of alkyl phosphate intoxication or where standard therapy fails.

摘要

相似文献

1
[Elimination of alkyl phosphates by means of haemoperfusion: experimental results and findings from human casuistics (author's transl)].
Anaesthesist. 1976 Dec;25(12):572-8.
2
[Hemoperfusion with coated activated charcoal for treating acute poisoning by remedies, plant protectants, and fungi (author's transl)].用包膜活性炭血液灌流治疗由药物、植物保护剂和真菌引起的急性中毒(作者译)
Med Klin. 1977 May 13;72(19):862-6.
3
Probable progress in the therapy of organophosphate poisoning: extracorporeal hemodialysis and hemoperfusion.有机磷中毒治疗的可能进展:体外血液透析和血液灌流。
Arch Toxicol. 1976 Jun 8;35(3):221-7. doi: 10.1007/BF00293570.
4
Therapeutic properties.of haemodialysis and blood exchange transfusion in organophosphate poisoning.血液透析和换血疗法在有机磷中毒中的治疗特性。
Eur J Intensive Care Med. 1976;2(1):13-8. doi: 10.1007/BF00571891.
5
[Treatment of severe hypnotic poisoning with extracorporeal haemoperfusion (author's transl)].体外血液灌流治疗严重催眠药中毒(作者译)
Dtsch Med Wochenschr. 1976 Jan 30;101(5):158-62. doi: 10.1055/s-0028-1104052.
6
[Hemoperfusion with XAD-4 resin in the treatment of a severe parathion intoxication (author's transl)].用XAD - 4树脂血液灌流治疗重度对硫磷中毒(作者译)
Arch Toxicol. 1979 Sep;42(4):311-5. doi: 10.1007/BF00334846.
7
Haemodialysis with charcoal haemoperfusion.血液透析联合血液灌流(使用活性炭)。
Proc Eur Dial Transplant Assoc. 1976;12:526-33.
8
Extracorporeal elimination of carbamazepine by haemoperfusion.通过血液灌流进行卡马西平的体外清除。
Biomater Artif Cells Immobilization Biotechnol. 1992;20(5):1171-6. doi: 10.3109/10731199209117344.
9
[Haemoperfusion with activated charcoal and ion exchanger in phalloidin intoxicated rats (author's transl)].
Dtsch Med Wochenschr. 1976 Mar 12;101(11):418-20.
10
Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazem.血液灌流对缓释型地尔硫䓬急性过量用药影响的药代动力学分析中的经验教训。
Anaesthesia. 2008 Jul;63(7):714-8. doi: 10.1111/j.1365-2044.2008.05477.x.